These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8615038

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Construction of a safe and efficient retrovirus packaging cell line.
    Markowitz D, Goff S, Bank A.
    Adv Exp Med Biol; 1988; 241():35-40. PubMed ID: 3223411
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Packaging system for rapid production of murine leukemia virus vectors with variable tropism.
    Landau NR, Littman DR.
    J Virol; 1992 Aug; 66(8):5110-3. PubMed ID: 1321291
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Retroviral gene transfer using safe and efficient packaging cell lines.
    Markowitz D, Hesdorffer C, Ward M, Goff S, Bank A.
    Ann N Y Acad Sci; 1990 Aug; 612():407-14. PubMed ID: 2291567
    [Abstract] [Full Text] [Related]

  • 28. Characterization of a polytropic murine leukemia virus proviral sequence associated with the virus resistance gene Rmcf of DBA/2 mice.
    Jung YT, Lyu MS, Buckler-White A, Kozak CA.
    J Virol; 2002 Aug; 76(16):8218-24. PubMed ID: 12134027
    [Abstract] [Full Text] [Related]

  • 29. A safe packaging line for gene transfer: separating viral genes on two different plasmids.
    Markowitz D, Goff S, Bank A.
    J Virol; 1988 Apr; 62(4):1120-4. PubMed ID: 2831375
    [Abstract] [Full Text] [Related]

  • 30. Safety considerations in vector development.
    Kappes JC, Wu X.
    Somat Cell Mol Genet; 2001 Nov; 26(1-6):147-58. PubMed ID: 12465466
    [Abstract] [Full Text] [Related]

  • 31. Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors.
    Savard N, Cosset FL, Epstein AL.
    J Virol; 1997 May; 71(5):4111-7. PubMed ID: 9094692
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Foamy virus vectors.
    Russell DW, Miller AD.
    J Virol; 1996 Jan; 70(1):217-22. PubMed ID: 8523528
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antibody-mediated targeting of replication-competent retroviral vectors.
    Tai CK, Logg CR, Park JM, Anderson WF, Press MF, Kasahara N.
    Hum Gene Ther; 2003 May 20; 14(8):789-802. PubMed ID: 12804141
    [Abstract] [Full Text] [Related]

  • 39. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences.
    Otto E, Jones-Trower A, Vanin EF, Stambaugh K, Mueller SN, Anderson WF, McGarrity GJ.
    Hum Gene Ther; 1994 May 20; 5(5):567-75. PubMed ID: 8054374
    [Abstract] [Full Text] [Related]

  • 40. A transient three-plasmid expression system for the production of high titer retroviral vectors.
    Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM, Kingsman AJ.
    Nucleic Acids Res; 1995 Feb 25; 23(4):628-33. PubMed ID: 7899083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.